Esophagus Cancer Completed Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02879227Radiochemotherapy in Elderly Patients With Oesophagus CancerTreatment